Back to search
Autoimmune Uveitis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Autoimmune Uveitis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Autoimmune Uveitis trials you may qualify forThis prospective study will include patients with Vogt-Koyanagi-Harada disease from disease onset, treated with early systemic high-dose corticosteroid and immu…
Immune-mediated inflammatory diseases (IMIDs) most often affect young patients and have high impact on morbidity and mortality with a significant alteration in…
This Phase 1b basket trial will investigate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity and preliminary efficacy of RAY121, a i…
The purpose of this study is twofold: 1. To analyze the clinical features of a cohort of patients with birdshot chorioretinopathy (BCR), an inflammatory bilate…
To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.
The purpose of this study is to learn about the experience of women with vasculitis who become pregnant. In particular, the study will consist of several online…
Introduction: Patients with autoimmune rheumatic diseases (ARDs), rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), psoriatic arthritis (PAs), ank…
This is a long-term extension trial of RAY121 in patients with immunological diseases such as antiphospholipid syndrome (APS), bullous pemphigoid (BP), Behçet's…
Vogt-Koyanagi-Harada (VKH) disease is a rare autoimmune disorder characterized by bilateral ocular inflammation that may lead to serous retinal detachment and p…